Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Breast Cancer

Free Subscription Articles published in BMJ Retrieve available abstracts of 48 articles: HTML format

Single Articles

March 2021
1. 
   Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
   BMJ. 2021;372:n738.
   PubMed    
   
   
   February 2021
2. MITTRA I, Mishra GA, Dikshit RP, Gupta S, et al
   Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
   BMJ. 2021;372:n256.
   PubMed     Abstract available
   
   
   
3. MN W, L J, Jw H, Ks R, et al
   Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.
   BMJ. 2021;372:n214.
   PubMed     Abstract available
   
   
   December 2020
4. DODWELL D, Jauhari Y, Gathani T, Cromwell D, et al
   Treatment variation in early breast cancer in the UK.
   BMJ. 2020;371:m4237.
   PubMed    
   
   
   November 2020
5. CHIN YR, Warner R
   Diffuse bruising on left breast.
   BMJ. 2020;371:m4179.
   PubMed    
   
   
   
6. KLEE G, Langan EA
   Just an odd rash?
   BMJ. 2020;371:m4032.
   PubMed    
   
   
   October 2020
7. VINOGRADOVA Y, Coupland C, Hippisley-Cox J
   Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
   BMJ. 2020;371:m3873.
   PubMed     Abstract available
   
   
   
8. GRIFFIN S
   Pause in breast cancer screening is opportunity to re-evaluate programme, says critic.
   BMJ. 2020;371:m3810.
   PubMed    
   
   
   September 2020
9. THORNTON H
   Blatant disregard to proper consent continues in screening programmes.
   BMJ. 2020;370:m3592.
   PubMed    
   
   
   
10. ZHANG Y, Birmann BM, Han J, Giovannucci EL, et al
    Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
    BMJ. 2020;370:m2942.
    PubMed     Abstract available
    
    
    August 2020
11. MAHASE E
    Trial to extend breast cancer screening won't resume randomisation after pandemic.
    BMJ. 2020;370:m3337.
    PubMed    
    
    
    
12. VAIDYA JS, Bulsara M, Baum M, Wenz F, et al
    Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    BMJ. 2020;370:m2836.
    PubMed     Abstract available
    
    
    
13. WISE J
    Breast cancer: study claiming that screening women in their 40s saves lives "found the opposite," say critics.
    BMJ. 2020;370:m3191.
    PubMed    
    
    
    May 2020
14. MANNU GS, Wang Z, Broggio J, Charman J, et al
    Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
    BMJ. 2020;369:m1570.
    PubMed     Abstract available
    
    
    
15. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    PubMed     Abstract available
    
    
    March 2020
16. TORJESEN I
    Health groups criticise EU funded breast cancer screening study as a "missed opportunity".
    BMJ. 2020;368:m855.
    PubMed    
    
    
    January 2020
17. MAHASE E
    AI system outperforms radiologists in first reading of breast cancer screening, study claims.
    BMJ. 2020;368:m16.
    PubMed    
    
    
    October 2019
18. RYMER J, Brian K, Regan L
    HRT and breast cancer risk.
    BMJ. 2019;367:l5928.
    PubMed    
    
    
    September 2019
19. DYER C
    Asylum seeker whose breast cancer treatment was delayed over eligibility has died.
    BMJ. 2019;366:l5692.
    PubMed    
    
    
    
20. MAHASE E
    Tell women about long term breast cancer risk with HRT, drug agency tells doctors.
    BMJ. 2019;366:l5350.
    PubMed    
    
    
    August 2019
21. MAHASE E
    Breast cancer risk associated with HRT increases with longer use, finds study.
    BMJ. 2019;366:l5332.
    PubMed    
    
    
    July 2019
22. MAHASE E
    Breast cancer: NICE approves new drug combination treatment.
    BMJ. 2019;366:l4727.
    PubMed    
    
    
    
23. CHAZELAS E, Srour B, Desmetz E, Kesse-Guyot E, et al
    Sugary drink consumption and risk of cancer: results from NutriNet-Sante prospective cohort.
    BMJ. 2019;366:l2408.
    PubMed     Abstract available
    
    
    June 2019
24. RICHMOND RC, Anderson EL, Dashti HS, Jones SE, et al
    Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.
    BMJ. 2019;365:l2327.
    PubMed     Abstract available
    
    
    
25. SCHERNHAMMER ES
    Larks, owls, and breast cancer.
    BMJ. 2019;365:l4267.
    PubMed    
    
    
    May 2019
26. MAHASE E
    Hormone therapy increases breast cancer risk in transgender women, study finds.
    BMJ. 2019;365:l2221.
    PubMed    
    
    
    
27. DE BLOK CJM, Wiepjes CM, Nota NM, van Engelen K, et al
    Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    BMJ. 2019;365:l1652.
    PubMed     Abstract available
    
    
    April 2019
28. BEWLEY S, Blennerhassett M, Payne M
    Cost of extending the NHS breast screening age range in England.
    BMJ. 2019;365:l1293.
    PubMed    
    
    
    
29. CHRISTIE B
    Tayside breast cancer patients are recalled after treatment is criticised.
    BMJ. 2019;365:l1542.
    PubMed    
    
    
    October 2018
30. MATTHEWS A, Stanway S, Farmer RE, Strongman H, et al
    Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review.
    BMJ. 2018;363:k3845.
    PubMed     Abstract available
    
    
    September 2018
31. THORNTON H
    Yet another risk score-will it really help decision making?
    BMJ. 2018;362:k3847.
    PubMed    
    
    
    July 2018
32. POTTER S, MacKenzie M, Blazeby JM
    Does the addition of mesh improve outcomes in implant based breast reconstruction after mastectomy for breast cancer?
    BMJ. 2018;362:k2607.
    PubMed    
    
    
    June 2018
33. MAYOR S
    Seven in 10 women with early breast cancer do not need chemotherapy, study finds.
    BMJ. 2018;361:k2473.
    PubMed    
    
    
    May 2018
34. BAGENAL J, Roche N, Ross G, Kirby A, et al
    Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?
    BMJ. 2018;361:k1410.
    PubMed    
    
    
    
35. HAWKES N
    Breast cancer screening error: fatal mistake or lucky escape?
    BMJ. 2018;361:k2036.
    PubMed    
    
    
    January 2018
36. WHITE H, Barrett M, Gooding C
    Chronic hip pain.
    BMJ. 2018;360:j5882.
    PubMed    
    
    
    
37. VAIDYA JS, Massarut S, Vaidya HJ, Alexander EC, et al
    Rethinking neoadjuvant chemotherapy for breast cancer.
    BMJ. 2018;360:j5913.
    PubMed    
    
    
    December 2017
38. MAYOR S
    Mammography screening reduces breast cancer deaths in Ireland, study finds.
    BMJ. 2017;359:j5932.
    PubMed    
    
    
    
39. KALAGER M
    Breast cancer screening.
    BMJ. 2017;359:j5625.
    PubMed    
    
    
    
40. AUTIER P, Boniol M, Koechlin A, Pizot C, et al
    Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    BMJ. 2017;359:j5224.
    PubMed     Abstract available
    
    
    November 2017
41. DYER C
    Woman who rejected breast cancer diagnosis may undergo surgery without her consent.
    BMJ. 2017;359:j5358.
    PubMed    
    
    
    
42. IACOBUCCI G
    NICE recommends routine NHS funding for new breast cancer drugs.
    BMJ. 2017;359:j5309.
    PubMed    
    
    
    
43. FEINMANN J
    Number of UK patients with metastatic breast cancer isn't known.
    BMJ. 2017;359:j5205.
    PubMed    
    
    
    
44. MAYOR S
    Risk of breast cancer recurrence remains for years after endocrine treatment ends, study finds.
    BMJ. 2017;359:j5167.
    PubMed    
    
    
    
45. NACHIAPPAN S, Howlett DC
    Renal transplant, previous breast cancer, and progressive breathlessness.
    BMJ. 2017;359:j4773.
    PubMed    
    
    
    October 2017
46. DIMITRAKOPOULOU VI, Tsilidis KK, Haycock PC, Dimou NL, et al
    Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    BMJ. 2017;359:j4761.
    PubMed     Abstract available
    
    
    
47. ROBERTSON E
    Patient commentary: the current model has failed.
    BMJ. 2017;359:j4568.
    PubMed    
    
    
    April 2017
48. CRAWFORD SM
    Cancer diagnostic centres must have high throughput.
    BMJ. 2017;357:j2070.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: